We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aerpio Pharmaceuticals Inc | NASDAQ:ARPO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.26 | 2.27 | 0 | 01:00:00 |
Delaware | 001-38560 | 61-1547850 | ||||||||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
17383 Sunset Boulevard, Suite A250 Pacific Palisades, California | 90272 | |||||||
(Address of principal executive offices) | (Zip code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common Stock, par value $0.0001 per share | AADI | The Nasdaq Stock Market LLC |
Broker | ||||||||||||||||||||
Director | For | Withheld | Non-Votes | |||||||||||||||||
Behzad Aghazadeh, Ph.D. | 8,361,137 | 1,669,427 | 3,895,640 | |||||||||||||||||
Richard Maroun | 9,872,401 | 158,163 | 3,895,640 | |||||||||||||||||
Emma Reeve | 9,871,998 | 158,566 | 3,895,640 |
For | Against | Abstentions | Broker Non-Votes | ||||||||
9,738,074 | 275,337 | 17,153 | 3,895,640 |
1 Year | 2 Years | 3 Years | Abstentions | Broker Non-Votes | ||||||||||
9,832,520 | 2,546 | 75,231 | 120,267 | N/A |
For | Against | Abstentions | ||||||
13,850,448 | 72,970 | 2,786 |
June 14, 2023 | /s/ Scott Giacobello | ||||
Scott Giacobello | |||||
Interim Chief Executive Officer and President, and Chief Financial Officer |
1 Year Aerpio Pharmaceuticals Chart |
1 Month Aerpio Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions